SCHEMBL30587154

SCHEMBL30587154

O=C(Nc1ccc(-c2nnc(-c3ccccc3)o2)cc1)c1ccccc1F

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMO Q99835 1/20 0.72
MEN1 O00255 3/20 0.65
KMT2A Q03164 3/20 0.65
TDP1 Q9NUW8 1/20 0.65
LCLAT1 Q6UWP7 2/20 0.65
RAB9A P51151 6/20 0.63
NPC1 O15118 5/20 0.63
KDM4E B2RXH2 3/20 0.63
MAPT P10636 3/20 0.63
SMN1; SMN2 Q16637 1/20 0.63
CHRNA7 P36544 5/20 0.62
ALDH1A1 P00352 2/20 0.62
L3MBTL1 Q9Y468 1/20 0.62
HSD17B10 Q99714 3/20 0.61
TP53 P04637 2/20 0.61
LMNA P02545 1/20 0.60
KCNH2 Q12809 3/20 0.60
USP2 O75604 1/20 0.60
TSHR P16473 1/20 0.60
MAPK1 P28482 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24473959 1.00 SMO (0.72) SMOMEN1KMT2ATDP1LCLAT1
SCHEMBL13878308 0.88 MEN1 (0.60) SMOMEN1KMT2ATDP1LCLAT1
SCHEMBL20522049 0.88 LCLAT1 (0.80) LCLAT1KDM4EMAPTALDH1A1HSD17B10
SCHEMBL30587145 0.84 SMO (1.00) SMOLCLAT1MAPTSMN1; SMN2HSD17B10
SCHEMBL26078521 0.84 SMO (0.72) SMOMEN1KMT2ARAB9ANPC1
SCHEMBL16384061 0.84 SMO (1.00) SMOLCLAT1MAPTSMN1; SMN2HSD17B10
SCHEMBL4033854 0.83 NPC1 (0.58) SMORAB9ANPC1KDM4EMAPT
SCHEMBL4241242 0.82 CHRNA7 (0.53) SMOMEN1KMT2ATDP1KDM4E
SCHEMBL24473971 0.81 ADCY1 (0.74) SMOMEN1KMT2ATDP1RAB9A
SCHEMBL24474016 0.80 LCLAT1 (0.68) SMOMEN1KMT2ALCLAT1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116457353-A N-substituted 4- (5-phenyl-1, 3, 4-oxadiazol-2-yl) anilines for the treatment and prophylaxis of hepatitis b virus infections 豪夫迈·罗氏有限公司 2023-07-18 CN claimed
CN-116457353-A N-substituted 4- (5-phenyl-1, 3, 4-oxadiazol-2-yl) anilines for the treatment and prophylaxis of hepatitis b virus infections 豪夫迈·罗氏有限公司 2023-07-18 CN disclosed